Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 4NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma 13HIV Infections 8Acquired Immunodeficiency Syndrome 8Testicular Neoplasms 6Hodgkin Disease 6Teratoma 5Lymphoma, Non-Hodgkin 5Testicular Germ Cell Tumor 4Sarcoma, Kaposi 4Lymphoma, Large B-Cell, Diffuse 3Endodermal Sinus Tumor 3Carcinoma, Embryonal 3Seminoma 2Recurrence 2Ovarian Neoplasms 2Ovarian Germ Cell Cancer 2Lymphoma, Large-Cell, Immunoblastic 2Teratoma, Testicular 1Squamous Cell Carcinoma of Head and Neck 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Nervous System Neoplasms 1Melanoma 1Lymphoma, Follicular 1Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1Head and Neck Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1Central Nervous System Neoplasms 1AIDS-Related Complex 1

Interventions

Rituximab 33Cyclophosphamide 23Filgrastim 18Peripheral Blood Stem Cell Transplantation 16Etoposide 13fludarabine phosphate 12Vincristine 12Prednisone 11Bortezomib 11sargramostim 10Radiotherapy 10Doxorubicin 8Cytarabine 8Cyclosporine 8Vorinostat 7Lenalidomide 7Cisplatin 7Biopsy 7tanespimycin 6Melphalan 6Magnetic Resonance Spectroscopy 6Ifosfamide 6bryostatin 1 5alvocidib 5aldesleukin 5Specimen Handling 5Methylprednisolone 5Methotrexate 5Interferon-alpha 5Gemcitabine 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Lymphoma, Follicular × Bleomycin × Clear all
NCT00005867 2013-06-26

Combination Chemotherapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma

National Cancer Institute (NCI)

Phase 3 Completed
310 enrolled
Lymphoid

Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡